B-Cell CLL/lymphoma 11A (Zinc Finger Protein) (BCL11A) Peptid
BCL11A
Reaktivität: Säugetier
Wirt: Synthetic
BP, WB, IHC
Produktnummer ABIN935999
368,61 €
Zzgl. Versandkosten 20,00 € und MwSt
100 μg
Lieferung nach:
Deutschland
Lieferung in 20 bis 27 Werktagen
Kurzübersicht für B-Cell CLL/lymphoma 11A (Zinc Finger Protein) (BCL11A) Peptid (ABIN935999)
Target
BCL11A
(B-Cell CLL/lymphoma 11A (Zinc Finger Protein) (BCL11A))
Spezies
Säugetier
Quelle
Synthetic
Applikation
Blocking Peptide (BP), Western Blotting (WB), Immunohistochemistry (IHC)
-
-
Protein-Typ
- Synthetic
-
Sequenz
- YACAQSSKLT RHMKTHGQVG KDVYKCEICK MPFSVYSTLE KHMKKWHSDR
-
Produktmerkmale
-
A synthetic peptide for use as a blocking control in assays to test for specificity of BCL11 A antibody,
Alternative Names: BCL11A control peptide, BCL11A antibody Blocking Peptide, Anti-BCL11A Blocking Peptide, B-cell CLL/lymphoma 11A, zinc finger protein Blocking Peptide, BCL11A-L Blocking Peptide, BCL11A-S Blocking Peptide, BCL11A-XL Blocking Peptide, CTIP1 Blocking Peptide, EVI9 Blocking Peptide, FLJ10173 Blocking Peptide, FLJ34997 Blocking Peptide, HBFQTL5 Blocking Peptide, KIAA1809 Blocking Peptide, ZNF856 Blocking Peptide, BCL11A, BCLA-11, BCLA 11, BCLA-11 Blocking Peptide, BCLA 11 Blocking Peptide -
Aufreinigung
- Cellsupernatant, Protein G purified, 50 mM TRIS pH 7,4 0,04% Thimerosal
-
-
-
-
Applikationshinweise
- Optimal conditions should be determined by the investigator
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Rekonstitution
- Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
-
Buffer
- PBS
-
Handhabung
- Avoid repeated freeze/thaw cycles.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- Store at -20 °C long term.
-
-
- BCL11A (B-Cell CLL/lymphoma 11A (Zinc Finger Protein) (BCL11A))
-
Hintergrund
- BCL11A is a C2H2 type zinc-finger protein by its similarity to the mouse Bcl11a/Evi9 protein. The corresponding mouse gene is a common site of retroviral integration in myeloid leukemia, and may function as a leukemia disease gene, in part, through its interaction with BCL6. During hematopoietic cell differentiation, this gene is down-regulated. It is possibly involved in lymphoma pathogenesis since translocations associated with B-cell malignancies also deregulates its expression.
-
Molekulargewicht
- 91 kDa
Target
-
Sie sind hier:
